COMBI-EU: adverse event management of adjuvant dabrafenib plus trametinib (D+T) in patients with BRAF V600-mutant melanoma - Mohr, Peter; Debus, Dirk; Wasielewski, Imke von; Tüting, Thomas; Gebhardt, Christoffer; Heppt, Markus V.; Hassel, Jessica C.; Ziller, Fabian; Weichenthal, Michael; Aoun, Manar; Schley, Gaston; Ulrich, Jens; et al. (Annals of oncology, 2024)